Comparison of two flow cytometric methods for detection of aneuploidy in multiple myeloma:: Implications for investigation of residual disease

被引：0
|
作者：
Oelschlaegel, U [1 ]
Nowak, R [1 ]
Heider, T [1 ]
Naumann, R [1 ]
Bornhäuser, M [1 ]
Ehninger, G [1 ]
机构：
[1] Univ Hosp, Med Clin 1, Dresden, Germany
来源：
EXPERIMENTAL HEMATOLOGY | 2003年 / 31卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
184
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [1] Introduction to Multiple Myeloma Special Issue: The Flow Cytometric Detection of Minimal Residual Disease
    Preffer, Frederic I.
    Yuan, Constance M.
    Lin, Pei
    Stetler-Stevenson, MaryAlice
    Marti, Gerald E.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2016, 90 (01) : 9 - 13
  • [2] FLOW CYTOMETRIC ANALYSIS AND MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA: A COMPARISON BETWEEN FLOW CYTOMETRIC IMMUNOPHENOTYPING AND CYCLOSCOPE-MG.
    De Tullio, G.
    Ria, R.
    Reale, A.
    Minoia, C.
    Serrati, S.
    Loseto, G.
    Vacca, A.
    Guarini, A.
    HAEMATOLOGICA, 2013, 98 : 337 - 337
  • [3] Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple Myeloma
    Gupta, Ritu
    Bhaskar, Archana
    Kumar, Lalit
    Sharma, Atul
    Jain, Paresh
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (05) : 728 - 732
  • [4] Flow Cytometric Immunophenotyping for Minimal Residual Disease Analysis in Multiple Myeloma.
    Gupta, Rita
    Bhaskar, Archana
    Jain, Paresh
    Sharma, Atul
    Kumar, Lalit
    BLOOD, 2008, 112 (11) : 937 - 937
  • [5] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Takeshi Yoroidaka
    Kentaro Narita
    Hiroyuki Takamatsu
    Momoko Fujisawa
    Shinji Nakao
    Kosei Matsue
    Scientific Reports, 11
  • [6] Comparison of minimal residual disease detection in multiple myeloma between the DuraClone and EuroFlow methods
    Yoroidaka, Takeshi
    Narita, Kentaro
    Takamatsu, Hiroyuki
    Fujisawa, Momoko
    Nakao, Shinji
    Matsue, Kosei
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Flow cytometric detection of aneuploidy for determining minimal residual disease in acute leukemia patients.
    Oelschlägel, U
    Nowak, R
    Herbst, R
    Krebs, U
    Schaub, A
    Köppel, C
    Bräutigam, E
    Kleine, HD
    Wendt, E
    Assmann, M
    Stamminger, S
    Schuler, U
    Ehninger, G
    EXPERIMENTAL HEMATOLOGY, 1998, 26 (08) : 786 - 786
  • [8] Harmonization of Flow Cytometric Minimal Residual Disease Assessment in Multiple Myeloma in Centers of Polish Myeloma Consortium
    Krzywdzinska, Agnieszka
    Pula, Bartosz
    Czyz, Anna
    Krzymieniewska, Beata
    Kiernicka-Parulska, Jolanta
    Mierzwa, Anna
    Szymczak, Donata
    Milanowska, Aneta
    Kiraga, Aleksandra
    Kwiecien, Iwona
    Zaleska, Joanna
    Jamroziak, Krzysztof
    DIAGNOSTICS, 2021, 11 (10)
  • [9] Minimal residual disease monitoring in multiple myeloma:: How specific is the flow cytometric analysis?
    Lioznov, M.
    Fehse, B.
    Zander, A.
    Kroeger, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 203 - 203
  • [10] Comparison of two flow cytometric approaches for detection of minimal residual disease in acute leukemia patients representing aberrant antigen expression and DNA-aneuploidy simultaneously.
    Oelschlaegel, U
    Nowak, R
    Range, U
    Herbst, R
    Koeppel, C
    Schaub, A
    Ehninger, G
    BLOOD, 2000, 96 (11) : 194B - 194B
12345